InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX)
CUSIP: N44821101
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / Common Shares, nominal value (euro)0.12 per share
- Shares outstanding
- 67,811,197
- Total 13F shares
- 4,411,616
- Share change
- -10,183,622
- Total reported value
- $13,940,000
- Price per share
- $3.16
- Number of holders
- 27
- Value change
- -$394,268,959
- Number of buys
- 18
- Number of sells
- 37
Quarterly Holders Quick Answers
What is CUSIP N44821101?
CUSIP N44821101 identifies IFRX - InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP N44821101:
Top shareholders of IFRX - InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
4.1%
|
2,810,708
|
$106,217,000 | — | 31 Mar 2019 | |
| Cormorant Asset Management, LP |
13F
|
Company |
3.8%
|
2,590,000
|
$97,876,000 | — | 31 Mar 2019 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
3.4%
|
2,271,959
|
$85,857,000 | — | 31 Mar 2019 | |
| Redmile Group, LLC |
13F
|
Company |
3.2%
|
2,182,638
|
$82,482,000 | — | 31 Mar 2019 | |
| Artal Group S.A. |
13F
|
Company |
1.2%
|
825,000
|
$31,177,000 | — | 31 Mar 2019 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
1.1%
|
732,670
|
$27,688,000 | — | 31 Mar 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.64%
|
431,821
|
$16,319,000 | — | 31 Mar 2019 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.41%
|
275,000
|
$10,392,000 | — | 31 Mar 2019 | |
| FMR LLC |
13F
|
Company |
0.37%
|
254,268
|
$9,609,000 | — | 31 Mar 2019 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.33%
|
225,000
|
$8,503,000 | — | 31 Mar 2019 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.26%
|
178,987
|
$6,764,000 | — | 31 Mar 2019 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
0.26%
|
175,414
|
$6,629,000 | — | 31 Mar 2019 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.24%
|
161,913
|
$6,119,000 | — | 31 Mar 2019 | |
| BAMCO INC /NY/ |
13F
|
Company |
0.2%
|
136,998
|
$5,177,000 | — | 31 Mar 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.17%
|
118,573
|
$4,481,000 | — | 31 Mar 2019 | |
| AXA S.A. |
13F
|
Company |
0.15%
|
99,890
|
$3,775,000 | — | 31 Mar 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.14%
|
95,095
|
$3,594,000 | — | 31 Mar 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.13%
|
86,317
|
$3,261,000 | — | 31 Mar 2019 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.12%
|
81,880
|
$3,094,000 | — | 31 Mar 2019 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.11%
|
77,547
|
$2,931,000 | — | 31 Mar 2019 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.11%
|
73,919
|
$2,793,000 | — | 31 Mar 2019 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.11%
|
72,000
|
$2,721,000 | — | 31 Mar 2019 | |
| EMORY UNIVERSITY |
13F
|
Company |
0.11%
|
71,884
|
$2,716,000 | — | 31 Mar 2019 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.1%
|
68,901
|
$2,604,000 | — | 31 Mar 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.09%
|
63,831
|
$2,412,000 | — | 31 Mar 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.09%
|
60,823
|
$2,299,000 | — | 31 Mar 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.09%
|
58,300
|
$2,203,000 | — | 31 Mar 2019 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.08%
|
52,197
|
$1,973,000 | — | 31 Mar 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.06%
|
37,368
|
$1,412,000 | — | 31 Mar 2019 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.05%
|
32,500
|
$1,223,000 | — | 31 Mar 2019 | |
| Birchview Capital, LP |
13F
|
Company |
0.02%
|
16,000
|
$605,000 | — | 31 Mar 2019 | |
| BlueCrest Capital Management Ltd |
13F
|
Company |
0.02%
|
15,000
|
$567,000 | — | 31 Mar 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
13,353
|
$504,000 | — | 31 Mar 2019 | |
| A.R.T. Advisors, LLC |
13F
|
Company |
0.02%
|
11,862
|
$448,000 | — | 31 Mar 2019 | |
| Gestion Carmignac |
13F
|
Individual |
0.02%
|
10,688
|
$404,000 | — | 31 Mar 2019 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.01%
|
10,000
|
$378,000 | — | 31 Mar 2019 | |
| Spark Investment Management LLC |
13F
|
Company |
0.01%
|
9,500
|
$359,000 | — | 31 Mar 2019 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.01%
|
9,114
|
$344,000 | — | 31 Mar 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
7,410
|
$280,000 | — | 31 Mar 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
854
|
$32,000 | — | 31 Mar 2019 | |
| Pearl River Capital, LLC |
13F
|
Company |
0%
|
660
|
$24,000 | — | 31 Mar 2019 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
510
|
$19,000 | — | 31 Mar 2019 | |
| UBS Group AG |
13F
|
Company |
0%
|
449
|
$17,000 | — | 31 Mar 2019 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
126
|
$5,000 | — | 31 Mar 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
105
|
$4,000 | — | 31 Mar 2019 | |
| Point72 Hong Kong Ltd |
13F
|
Company |
0%
|
24
|
$1,000 | — | 31 Mar 2019 |
Institutional Holders of InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX) as of Q2 2019
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q1 2019 Across Filers
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.